PLX

PROTALIX BIOTHER
AMEX

Real-time Quotes | Nasdaq Last Sale

3.610
-0.070
-1.91%
Opening 12:11 08/06 EDT
OPEN
3.760
PREV CLOSE
3.680
HIGH
3.760
LOW
3.605
VOLUME
46.83K
TURNOVER
--
52 WEEK HIGH
4.865
52 WEEK LOW
1.700
MARKET CAP
117.11M
P/E (TTM)
-5.5862
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PLX stock price target is 9.75 with a high estimate of 11.00 and a low estimate of 8.50.

EPS

PLX News

More
Protalix BioTherapeutics to Hold Second Quarter 2020 Financial Results and Business Update Conference Call on August 10, 2020
CARMIEL, Israel, Aug. 3, 2020 /PRNewswire/Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary
PR Newswire · 3d ago
Protalix reports Non-Binding Term Sheet With SarcoMed To Develop Alidornase Alfa For Treatment Of Pulmonary Sarcoidosis, Related Diseases
Protalix BioTherapeutics, Inc. (NYSE:PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary
Benzinga · 07/23 18:31
Protalix BioTherapeutics Enters into Non-Binding Term Sheet with SarcoMed USA to Develop alidornase alfa for the Treatment of Pulmonary Sarcoidosis and Related Diseases
Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expres
PR Newswire · 07/23 18:29
Edited Transcript of PLX.A earnings conference call or presentation 1-Jun-20 12:30pm GMT
Q1 2020 Protalix Biotherapeutics Inc Earnings Call
Thomson Reuters StreetEvents · 07/22 23:28
Have Insiders Been Buying Protalix BioTherapeutics, Inc. (NYSEMKT:PLX) Shares?
Simply Wall St. · 06/18 17:20
Protalix: Investors Should Bear 'Balance' In Mind When Considering The Fabry BLA
Seeking Alpha - Article · 06/16 15:23
Protalix Undervalued Due To Ghost Of Shire, Upside On Fabry Approval Significant
Seeking Alpha - Article · 06/09 12:23
Protalix BioTherapeutics Appoints Yael Hayon, Ph.D. as its New Vice President, Research and Development
Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX) today announced the appointment of Yael Hayon, Ph.D. as the Company's new Vice President, Research and Development, effective July 5, 2020. On June 2, 2020, Yoseph Shaaltiel, Ph.D. retired from hi
PR Newswire · 06/08 21:00

Industry

Biotechnology & Medical Research
-1.49%
Pharmaceuticals & Medical Research
-0.86%

Hot Stocks

Symbol
Price
%Change

About PLX

Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other Latin American countries and Elelyso in the rest of the territories) for the treatment of Gaucher disease that has been approved for marketing in the United States, Brazil, Israel and other markets. The Company's product pipeline includes PRX-102 for the treatment of Fabry disease; AIR DNase (PRX-110) for Cystic Fibrosis, and Oral Anti-TNF (OPRX-106) Anti Inflammatory. PRX-102 or alpha-GAL-A is an enzyme replacement therapy product for the treatment of Fabry disease. AIR DNase is a plant cell recombinant human Deoxyribonuclease 1. Oral Anti-TNF represents a mode of administering a recombinant anti-TNF protein.
More

Webull offers kinds of Protalix Biotherapeutics Inc stock information, including AMEX:PLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PLX stock methods without spending real money on the virtual paper trading platform.